Lantheus Holdings (LNTH) Total Liabilities (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Total Liabilities of $1.1 billion for Q1 2026, up 27.3% year-over-year from $891.0 million in Q1 2025, and little changed quarter-over-quarter from $1.1 billion in Q4 2025.
Lantheus Holdings (LNTH) Total Liabilities (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Total Liabilities for 13 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 27.3% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 27.3% YoY), while the FY2025 annual figure was $1.1 billion, up 27.49% from the prior year.
- Total Liabilities held at $1.1 billion in Q1 2026 per LNTH's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $1.2 billion in Q3 2025 and bottomed at $417.3 million in Q1 2022.
- Historically, Total Liabilities has averaged $845.5 million across 5 years, with a median of $885.8 million in 2024.
- Annual changes were most pronounced in 2022 — Total Liabilities soared 118.89% — and 2023, when it retreated 4.44%.
- Lantheus Holdings' Total Liabilities stood at $874.1 million in 2022, then declined by 4.44% to $835.3 million in 2023, then increased by 6.83% to $892.3 million in 2024, then climbed by 27.49% to $1.1 billion in 2025, then slipped by 0.29% to $1.1 billion in 2026.
- Business Quant data shows LNTH's Total Liabilities at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 1.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Bn |
| Mar 31, 2026 | 1.13 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 949.29 Mn |
| Mar 31, 2025 | 891.03 Mn |
| Dec 31, 2024 | 892.33 Mn |
| Sep 30, 2024 | 869.92 Mn |
| Jun 30, 2024 | 913.15 Mn |
| Mar 31, 2024 | 885.79 Mn |
| Dec 31, 2023 | 835.26 Mn |
| Sep 30, 2023 | 822.85 Mn |
| Jun 30, 2023 | 785.08 Mn |
| Mar 31, 2023 | 903.77 Mn |
| Dec 31, 2022 | 874.11 Mn |
| Sep 30, 2022 | 457.89 Mn |
| Jun 30, 2022 | 446.49 Mn |
| Mar 31, 2022 | 417.32 Mn |
| Dec 31, 2021 | 399.35 Mn |
| Sep 30, 2021 | 348.47 Mn |